EUVIMEDEUVIMED entdecken
QuerschnittstudieOpen Access · CC BY 4.0

Elevated high sensitivity cardiac troponin T among men with HIV who use stimulants: A cross-sectional study of subclinical cardiovascular injury

Michaela E Larson iD, Yue Pan iD, Lisa Reidy, Emily M Cherenack, Sabina Hirshfield, Keith J Horvath, Elise D Riley, Savita Pahwa, Suresh Pallikkuth, Claudia Martinez iD, Adam W Carrico

PLOS One · 08.06.2026 · 21 (6) · e0350086

DOI: 10.1371/journal.pone.0350086 ↗

Kurz gefasst

Querschnittstudie in der Zeitschrift PLOS One, online erschienen am 08.06.2026. Verfasst von Michaela E Larson und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology, School of Public Health and Social Work, Florida International University, Miami, Florida, United States of America. Hauptthemen laut MEDLINE: Troponin T, HIV Infections, Cardiovascular Diseases, Central Nervous System Stimulants. Die Arbeit nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institute on Drug Abuse, National Institute of Allergy and Infectious Diseases, National Institute of Mental Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

People with HIV (PWH) experience elevated cardiovascular disease risk compared to people without HIV. Stimulant use may further increase subclinical myocardial injury among PWH, but data on cardiovascular biomarkers, including serum high-sensitivity cardiac troponin T (hs-cTnT) in this population is limited. This cross-sectional secondary analysis included 72 cisgender men with and without HIV enrolled in a South Florida cohort. Stimulant exposure was defined as any non-prescribed stimulant use in the past 3 months and/or a reactive urine toxicology screen, creating four HIV-by-stimulant use groups (i.e., HIV+Stim + , HIV+Stim-, HIV-Stim + , and HIV-Stim-). hs-cTnT was measured using a Roche high-sensitivity assay, with values below the limit of detection treated as undetectable. We used a two-part model (logistic for detectability; log-normal among participants with detectable hs-cTnT), adjusted for age and recent tobacco use, with sensitivity analyses adding renal function and cardiometabolic factors. After adjusting for age and recent tobacco use, HIV+Stim+ participants had higher odds of detectable hs-cTnT (aOR = 7.48, 95% CI: 1.25, 44.62) and higher estimated mean concentration of hs-cTnT (β = 0.51, p = 0.031, mean = 12) than the HIV-Stim- group. Exploratory analyses suggested a positive dose-response association between amphetamine metabolite levels and hs-cTnT ( r (11) = 0.86, p < 0.0001). Co-occurring HIV and stimulant use were associated with higher hs-cTnT in this sample. However, given that hs-cTnT may reflect a range of acute, subacute, and chronic processes, and the small sample size and restricted generalizability, these findings should be interpreted as exploratory and hypothesis-generating and require confirmation in larger studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Troponin THIV InfectionsCardiovascular DiseasesCentral Nervous System StimulantsHumansMaleCross-Sectional StudiesAdultMiddle AgedBiomarkers

Substanzen

Troponin TBiomarkersCentral Nervous System Stimulants

Autor:innen und Institutionen

  • Department of Epidemiology, School of Public Health and Social Work, Florida International University, Miami, Florida, United States of America.
  • Department of Public Health Sciences, University of Miami Miller School of Medicine, Miami, Florida, United States of America.
  • Department of Pathology and Laboratory Medicine, University of Miami Miller School of Medicine, Miami, Florida, United States of America.
  • Department of Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine, Miami, Florida, United States of America.
  • Department of Medicine, STAR Program, State University of New York Downstate Health Sciences University, Brooklyn, New York, United States of America.
  • Department of Psychology, San Diego State University, San Diego, California, United States of America.

ORCID-Profile: Michaela E Larson, Yue Pan, Claudia Martinez

Förderung

  • National Institute on Drug Abuse
  • National Institute of Allergy and Infectious Diseases
  • National Institute of Mental Health

Zitieren

APA

Larson, M. E., Pan, Y., Reidy, L., Cherenack, E. M., Hirshfield, S., Horvath, K. J., Riley, E. D., Pahwa, S., Pallikkuth, S., Martinez, C., & Carrico, A. W. (2026). Elevated high sensitivity cardiac troponin T among men with HIV who use stimulants: A cross-sectional study of subclinical cardiovascular injury. PLOS One, 21(6), e0350086. https://doi.org/10.1371/journal.pone.0350086

Vancouver

Larson ME, Pan Y, Reidy L, Cherenack EM, Hirshfield S, Horvath KJ, et al. Elevated high sensitivity cardiac troponin T among men with HIV who use stimulants: A cross-sectional study of subclinical cardiovascular injury. PLOS One. 2026;21(6):e0350086. doi:10.1371/journal.pone.0350086

BibTeX
@article{Larson2026,
  author = {Larson, Michaela E and Pan, Yue and Reidy, Lisa and Cherenack, Emily M and Hirshfield, Sabina and Horvath, Keith J and Riley, Elise D and Pahwa, Savita and Pallikkuth, Suresh and Martinez, Claudia and Carrico, Adam W},
  title = {Elevated high sensitivity cardiac troponin T among men with HIV who use stimulants: A cross-sectional study of subclinical cardiovascular injury},
  journal = {PLOS One},
  year = {2026},
  volume = {21},
  number = {6},
  pages = {e0350086},
  doi = {10.1371/journal.pone.0350086}
}
Kostenlos starten →